Henry Hazlitt, MD
Clinical Cardiac Electrophysiology · Clearwater, FLNPI 1457332553
Payments from drug & device makers
Across 478 payments — averaging $441.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$190K
- Boston Scientific$13K
- Biotronik Inc.$4K
- Biosense Webster, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$616
- Abbott$468
- plus $1K from 19 others
What the payments were for
- Travel & lodging$3,74725%
- Food & beverage$11,12274%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 213 | $190,376 |
| Boston Scientific | 107 | $12,738 |
| Biotronik Inc. | 21 | $4,368 |
| Biosense Webster, Inc. | 24 | $1,083 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 44 | $616 |
| Abbott | 13 | $468 |
| Acutus Medical, Inc. | 1 | $220 |
| AstraZeneca | 13 | $217 |
| Atricure, Inc. | 2 | $157 |
| Amgen | 8 | $153 |
| Novartis | 8 | $127 |
| Inspire Medical Systems, Inc. | 1 | $122 |
| Cardiva Medical, Inc. | 2 | $87 |
| Pfizer | 4 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Johnson & Johnson | 3 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Bardy Diagnostics, Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Cardiofocus, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Vektor Medical Inc. | 1 | $14 |
| Teleflex LLC | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,059
- WATCHMAN Access System$358
- Carto 3$286
- Adapta$270
- Farapulse$265
- Watchman$244
- Carto 3 System$236
- EMBLEM$233
- Acticor 7 VR-T DX$165
- Selectra$165
- RESONATE EL ICD VR$154
- Assurity Pacemaker$145
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$137
- LifeVest$126
- RHYTHMIA$125
- GENERAL TACHY$123
- Inspire$122
- OCTARAY MAPPING CATHETER$119
- Claria MRI$118
- ARCTIC FRONT ADVANCE$114
How this compares
$211,089 in reported general payments places this provider in the 85th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 386 | $411,848 |
| VyndamaxTafamidis | 14 | $308,616 |
| XareltoRivaroxaban | 143 | $185,263 |
| MultaqDronedarone Hcl | 41 | $72,418 |
| EntrestoSacubitril/Valsartan | 37 | $51,485 |
| FarxigaDapagliflozin Propanediol | 39 | $42,847 |
| Repatha SureclickEvolocumab | 24 | $34,229 |
| Flecainide Acetate | 207 | $7,608 |
| Dofetilide | 15 | $5,340 |
| Metoprolol Succinate | 255 | $3,158 |
| Amiodarone Hcl | 111 | $2,462 |
| SotalolSotalol Hcl | 49 | $1,729 |
| Ranolazine ErRanolazine | 14 | $1,225 |
| Potassium Chloride | 53 | $1,215 |
| Propafenone Hcl | 23 | $1,178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Vyndamax | $69 | $720,463400 claims |
| Johnson & JohnsonXarelto | $42 | $185,263143 claims |
| Sanofi-aventis U.S. LLCMultaq | $54 | $72,41841 claims |
| NovartisEntresto | $127 | $51,48537 claims |
| AstraZenecaFarxiga | $217 | $42,84739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Clearwater
- Jose Osorio FilhoMiami$16.4M
- Saumil OzaJacksonville$4.1M
- Usman SiddiquiWinter Park$3.6M
- David KenigsbergFort Lauderdale$1.3M
- Venkata SagiJacksonville$1.2M
- Raul WeissMiami Beach$1.1M
- Robert FishelAtlantis$1.1M
- Naushad ShaikKissimmee$1.1M
- Neal KaveshLakeland$967K
- Antonio MorettaSarasota$891K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.